期刊： NEURO-ONCOLOGY, 2023; 25 (6)
Background High-grade gliomas are malignant brain tumors characterized by aggressiveness and resistance to chemotherapy. Prognosis remains dismal, hig......
期刊： NEURO-ONCOLOGY, 2023; 25 (11)
Background Chimeric antigen receptor (CAR) T cell therapy has proven to be successful against hematological malignancies. However, exploiting CAR T ce......
期刊： NEURO-ONCOLOGY, 2023; 25 (12)
Background Glioblastoma (GBM) stem-like cells (GSCs) are crucial drivers of treatment resistance and tumor recurrence. While the concept of migrating ......
